Jobs / United States / Glaxosmithkline LLC
Field Based Medical Affairs Manager (Oncology)
Glaxosmithkline LLC · 🇺🇸 Petaling Jaya Horizon Penthouse
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Sr Manager - Oncology Commercial Analytics, Multiple Myeloma” (Data Scientists) in PA: $135k–$135k, median $135k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
As a Field‑Based Medical Affairs Manager (Oncology), this role will provide YOU the opportunity to execute external scientific engagement and medical initiatives in alignment with the local oncology medical strategy. The role is primarily field‑based and focuses on peer‑to‑peer scientific exchange, generation of actionable medical insights, and delivery of medical projects that support patient care, evidence generation, and informed internal decision‑making, while ensuring the highest standards of regulatory, ethical, and scientific integrity. We value curiosity, scientific rigour, strong communication skills, and a collaborative mindset. This role offers the opportunity for meaningful impact, continuous development, and contribution to GSK’s purpose of uniting science, technology, and talent to get ahead of disease together Responsibilities This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • Build, maintain, and deepen trusted scientific relationships with oncologists, cancer specialists, and other relevant healthcare professionals. • Deliver accurate, balanced, and non‑promotional scientific exchange on disease areas, clinical data, and emerging evidence. • Capture, synthesize, and communicate high‑quality medical insights from external engagements to inform strategy, planning, and evidence needs. • Support the planning and execution of advisory boards, medical education programs, workshops, and congress activities . • Contribute to local medical initiatives, and external collaborations where appropriate. • Support internal scientific capability building through delivery of medical updates and training when appropriate. • Ensure all interactions and materials follow legal, regulatory and ethical requirements and GSK standards. Collaboration and impact You will work closely with medical, clinical, regulatory and commercial colleagues. You will act as a bridge between external scientific communities and internal teams. You will help shape local medical strategies and contribute to projects that improve patient outcomes. You will be expected to work independently in the field while staying connected to the wider medical team. Why You? Qualification We are seeking professionals with the following required skills and qualifications to help us achieve our goals: • Medical degree (MBBS/MD), pharmacy degree (BPharm/PharmD), or postgraduate degree (Master’s or PhD) in a relevant life sciences discipline • Minimum 2 years relevant experience in medical affairs or related roles, preferably in oncology. • Strong understanding of oncology disease areas and clinical data interpretation . • Demonstrated ability to build credible, professional relationships with healthcare professionals. • Familiarity with the Malaysian healthcare and oncology ecosystem . • Ability and willingness to travel regularly within Malaysia and attend scientific meetings as needed. This role is field-based with regular office and virtual collaboration. Skills Digital Fluency, Enterprise Thinking, External Stakeholder Management, High Impact Communication, Launch Excellence Why GSK? Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact h